Intrinsiqq
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$476M
EPS-$0.53
P/E-2.99
P/FCF-3.29
EV/EBITDA-2.61
FCF Yield–
Div. Yield–
Net Debt/FCF0.5x
Sana Biotechnology, Inc. intrinsic value
52-Week Range
$1.59$4.77

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$149M

▲ +8.5% YoY

Op. Margin

–

ROIC

-55.22%

▼ -9.1pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$145M

▲ +43.6% YoY

Op. Cash Flow (TTM)

-$142M

▲ +35.5% YoY

Net Debt

-$68M

Net Cash Position

Cash & Equiv.

$122M

Continue Research

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SANA

CompareIntrinsic value
HALOHalozyme Therapeutics Inc.
$91.35-1.82%70
SCLXScilex Holding Company
$0.57-12.95%0
ACOGAlpha Cognition Inc.
$9.00+1.69%10
RGNXRegenxbio Inc.
$7.16-0.28%36
SLDBSolid Biosciences Inc.
$6.25-2.95%10
ADMAAdma Biologics Inc.
$13.17-1.27%82
RLAYRelay Therapeutics Inc.
$16.12+1.32%40
RVMDRevolution Medicines Inc.
$161.20+1.11%10

Held by ETFs

SANA is in 18 US ETFs. The largest of them, with SANA's weight in each:

Sana Biotechnology (SANA) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-2.99
Negative: a loss over the last twelve months. Price to free cash flow -3.29.
Financials

Questions about Sana Biotechnology

Does Sana Biotechnology (SANA) pay a dividend?

No. Sana Biotechnology (SANA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 29 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in SANA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SANA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.